» Articles » PMID: 22505926

Anoikis Resistance: an Essential Prerequisite for Tumor Metastasis

Overview
Journal Int J Cell Biol
Publisher Wiley
Specialty Cell Biology
Date 2012 Apr 17
PMID 22505926
Citations 223
Authors
Affiliations
Soon will be listed here.
Abstract

Metastasis is a multistep process including dissociation of cancer cells from primary sites, survival in the vascular system, and proliferation in distant target organs. As a barrier to metastasis, cells normally undergo an apoptotic process known as "anoikis," a form of cell death due to loss of contact with the extracellular matrix or neighboring cells. Cancer cells acquire anoikis resistance to survive after detachment from the primary sites and travel through the circulatory and lymphatic systems to disseminate throughout the body. Because recent technological advances enable us to detect rare circulating tumor cells, which are anoikis resistant, currently, anoikis resistance becomes a hot topic in cancer research. Detailed molecular and functional analyses of anoikis resistant cells may provide insight into the biology of cancer metastasis and identify novel therapeutic targets for prevention of cancer dissemination. This paper comprehensively describes recent investigations of the molecular and cellular mechanisms underlying anoikis and anoikis resistance in relation to intrinsic and extrinsic death signaling, epithelial-mesenchymal transition, growth factor receptors, energy metabolism, reactive oxygen species, membrane microdomains, and lipid rafts.

Citing Articles

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Dieli R, Lioy R, Crispo F, Cascelli N, Martinelli M, Lerose R Biomolecules. 2025; 15(2).

PMID: 40001578 PMC: 11853026. DOI: 10.3390/biom15020275.


Roles of anoikis in hepatocellular carcinoma: mechanisms and therapeutic potential.

Chen C, Wang M, Tu D, Cao J, Zhang C, Bai D Med Oncol. 2025; 42(3):58.

PMID: 39885089 DOI: 10.1007/s12032-025-02612-9.


The crucial role of CEMIP in cancer metastasis: Mechanistic insights and clinical implications.

Ko Y, Jo J, Song S, Lee H FASEB J. 2025; 39(1):e70284.

PMID: 39758005 PMC: 11701794. DOI: 10.1096/fj.202402522R.


Rearranging to resist cell death.

Brokatzky D, Mostowy S Elife. 2024; 13.

PMID: 39680433 PMC: 11649232. DOI: 10.7554/eLife.104942.


Identification of anoikis-related molecular patterns and the novel risk model to predict prognosis, tumor microenvironment infiltration and immunotherapy response in bladder cancer.

Zhu L, Xiao F, Hou Y, Huang S, Xu Y, Guo X Front Immunol. 2024; 15:1491808.

PMID: 39664392 PMC: 11631915. DOI: 10.3389/fimmu.2024.1491808.


References
1.
Diamond M, Sun L, Ottaviano A, Joseph M, Munshi H . Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci. 2008; 121(Pt 13):2197-207. DOI: 10.1242/jcs.021782. View

2.
Takeyama Y, Sato M, Horio M, Hase T, Yoshida K, Yokoyama T . Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett. 2010; 296(2):216-24. PMC: 3110825. DOI: 10.1016/j.canlet.2010.04.008. View

3.
Uttamsingh S, Bao X, Nguyen K, Bhanot M, Gong J, Chan J . Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene. 2007; 27(18):2626-34. DOI: 10.1038/sj.onc.1210915. View

4.
Chanvorachote P, Nimmannit U, Lu Y, Talbott S, Jiang B, Rojanasakul Y . Nitric oxide regulates lung carcinoma cell anoikis through inhibition of ubiquitin-proteasomal degradation of caveolin-1. J Biol Chem. 2009; 284(41):28476-28484. PMC: 2788896. DOI: 10.1074/jbc.M109.050864. View

5.
Derksen P, Liu X, Saridin F, van der Gulden H, Zevenhoven J, Evers B . Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell. 2006; 10(5):437-49. DOI: 10.1016/j.ccr.2006.09.013. View